References
Neurol Genet. 2018 Jan 18;4(1):e211. 
J Immunol (2003) 171 (2): 594–599.
Acta Neuropathol. 2023; 145(6): 749–772. 

--- 

Support this podcast: <a href="https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/support" rel="payment">https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/support</a>

BioMedical Portrait IV. c3. Two down-regulated microglial polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy distinct LDL binding proteins typically cargo oxy cholesterol.

Become a Paid Subscriber: https://anchor.fm/dr-daniel-j-guerra/subscribe


Become a Paid Subscriber: https://anchor.fm/dr-daniel-j-guerra/subscribe

You have wisely landed upon Authentic Biochemistry, with Dr. Daniel J Guerra, where published biochemical, physiological, genetic and immunological research along with biomedical and pharmaceutical science are interrogated.

Anchor (from Spotify)

Authentic Biochemistry

BioMedical Portrait IV. HLA disease including neuropatholgies. The Nasu-Hakola, a.k.a. polycystic lipomembranous osteodysplasia associated TREM2 disease. DJGPhD.04Oct2023.Authentic Biochemistry.

BioMedical PortraitIV.NHD patient fibroblasts used to generate iPSC's differentiated into Induced microglia like cells (iMGLs) pathophenocopied TREM2 mutations and lysosomal malfunctions.DJGPhD.